Background: In China, the isolation rate of fluconazole-resistant isolates of Candida tropicalis, together with fatality in cases of bloodstream infections due to this yeast, have increased annually.
Aims: This study investigates the clinical characteristics, risk factors, and prognostic factors of fluconazole-resistant C. tropicalis bloodstream infections (BSI).
Methods: A retrospective study analyzed clinical data of patients with C. tropicalis BSI from July 2013 to June 2019, focusing on clinical characteristics, risk factors, treatment regimens, and prognosis. Univariate analysis of risk factors and prognosis was conducted using x2 test or Fisher's exact tests. Binary logistic regression model for risk factors, and Cox regression method for prognosis, were used for multivariate analysis.
Results: The study enrolled 100 patients with C. tropicalis BSI, including 44 fluconazole-resistant and 56 fluconazole-sensitive cases; 64 patients were cured and 36 died, resulting in a mortality rate of 36%. Logistic regression analysis identified exposure to azole antifungal agents during the 2 weeks prior to the onset of the BSI as a risk factor for fluconazole resistance. Cox regression analysis showed that hematological malignancy, fluconazole-resistant strains, indwelling catheters, and chronic obstructive pulmonary disease were independent risk factors for patient mortality. Conversely, targeted therapy with sensitive antifungal agents and removal of drainage tubes were protective factors for survival.
Conclusions: Azole exposure led to the development of fluconazole resistance in C. tropicalis BSI; hematologic malignancies, azole resistance, chronic obstructive pulmonary disease and having intravenous catheters increased mortality rate. The use of echinocandins or amphotericin B and catheter removal improved outcomes, underscoring the need for early resistance detection and targeted treatment.
扫码关注我们
求助内容:
应助结果提醒方式:
